Sun World Newsletter

Scientific Studies

Cognitive decline in diabetic patients

Cognitive decline in diabetic patients


While in a person with type 1 diabetes just certain cognitive functions are altered, like attention, information processing velocity, visual reconstruction of an event and mental flexibility, in type 2 diabetes patients the psychomotor functions, the velocity of execution of certain actions and memory are severely impaired.

A recent study initially published in 2013 by the American Alzheimer Association has proven that the patients with high level of sugar in their blood also associated a hyperproduction of proteins that induced a toxic effect at cerebral level. Other clinical studies proved that patients diagnosed with type 2 diabetes have a 20% higher risk for mild cognitive impairment, with a 50% higher risk for Alzheimer disease and a 2.5-fold higher risk for developing vascular dementia somewhere in the future.

It is well known that patients older than 70 years of age, diagnosed with diabetes are more exposed to stroke or to cerebral infarction.

Introducing Glucolin Forte in their therapeutically scheme, supports optimal glycemic level and decreases the risk of major cerebrovascular events.

Glucolin Fortea unique product with a unique formulation that assures the following benefits:

  • Ensures blood glucose lowering by reducing the amount of glucose produced by the liver and increases the body’s ability to efficiently use glucose;
  • Support the regeneration of pancreatic beta cells and stimulates insulin production;